Suppressor factors and their potential for immunotherapy, and chemical influences on interferons.
D000818:Animals; D000242:Cyclic AMP / Q000494:pharmacology; D006152:Cyclic GMP / Q000494:pharmacology; D004686:Encephalomyocarditis virus; D004769:Enterovirus Infections / Q000401:mortality / Q000628:therapy; D000939:Epitopes; D005849:Gerbillinae; D006801:Humans; D007105:Immune Complex Diseases / Q000628:therapy; D007167:Immunotherapy; D007372:Interferons / Q000096:biosynthesis / Q000378:metabolism*; D008222:Lymphokines / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D008814:Mice, Inbred NZB; D011070:Poly I-C / Q000627:therapeutic use; D051381:Rats; D013491:Suppressor Factors, Immunologic; D013552:Swine; D013947:Thymosin / Q000494:pharmacology
D000939:Epitopes; D008222:Lymphokines; D013491:Suppressor Factors, Immunologic; C013256:soluble immune response suppressor; D013947:Thymosin; D007372:Interferons; D000242:Cyclic AMP; D006152:Cyclic GMP; D011070:Poly I-C